207334
-8%
29,11 €
26,71 €
NS LIPIBEN+ Q10 is a food supplement based on Red Rice Yeast, Silimarina and Coenzima Q10.
Monacoline K of red yeast rice contributes to normal blood cholesterol levels.
With this product, you earn 53 loyalty point(s). 53 point(s) = 0,53 €.
ACTION AND DESCRIPTION
NS LIPIBEN+ Q10 is a food supplement based on Red Rice Yeast, Silimarina and Coenzima Q10. Monacoline K of red yeast rice contributes to normal blood cholesterol levels. The beneficial effect is obtained with a daily intake of 10 mg of Monacolina K from fermented preparations of red yeast rice. Marian cardo contributes to liver protection.
CONSERVATION AND DACITY
Keep in a cool and dry place.
INGREDIENTS
Cargo agent: Celulous; Rice red yeast (Monascus purpureus, 5% Monaco K); Dry extract of marian meat seeds (Silybum Marianum, 80% Silimarin); Stabilizer: Hydroxypropylene; Stabilizing: Carboxymethylcellulose interlaced; Coating agent:
Nutritional values per tablet (618.12 mg):
energy value: 4.36 U (1.03 kcal);
fats: 0.02 g; of which saturated: 0.003 g
carbohydrates: 0.19 g, of which sugars: 0.01 g
food fibre: 0.32 g
protein: 0.01 g
salt: 0.02 g.
Nutritional information per tablet (618.12 mg):
Rice red yeast: 200 mg; [Monacolina K: 10 mg); E.S.
Marian meat seeds: 50 mg; (Silimerina: 40 mgl;
Coenzima Q10 (Ubiquinone): 10 mg.
EMPLEMENTATION MODEL
Take a tablet a day, preferably at night.
PRECAUTIONS AND WARNINGS
Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle.
Keep out of reach of younger children.
Do not exceed the daily recommended dose.
Recommended from the age of 18.
Pregnant and breastfeeding women, people with liver, kidney or muscle problems, children, adolescents and over 70 years of age, people under medical control and statin intolerants, should consult with the pharmacist or doctor before taking the food supplement.
USE IN PACIENTS WITH INTOLERANCIA ALIMENTARIA
This product can be taken by a celiac person, allergic/intolerant to the egg, or intolerant to the milk.
Project co-financed by the European Social Fund Asturias 2014/2020, within the Consolidation operation Ticket Empresarial 2016